The Ensign Group, Inc. (NASDAQ:ENSG) Director John G. Nackel sold 4,000 shares of the stock in a transaction on Tuesday, October 9th. The shares were sold at an average price of $39.00, for a total value of $156,000.00. Following the transaction, the director now directly owns 78,232 shares of the company’s stock, valued at $3,051,048. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

The Ensign Group stock opened at $38.45 on Friday. The Ensign Group, Inc. has a one year low of $20.81 and a one year high of $40.64. The company has a debt-to-equity ratio of 0.49, a current ratio of 1.42 and a quick ratio of 1.42. The firm has a market capitalization of $1.98 billion, a PE ratio of 32.04, a P/E/G ratio of 1.48 and a beta of 0.65.

The Ensign Group (NASDAQ:ENSG) last posted its quarterly earnings results on Thursday, August 2nd. The company reported $0.44 EPS for the quarter, topping the Zacks’ consensus estimate of $0.43 by $0.01. The Ensign Group had a return on equity of 15.61% and a net margin of 3.61%. The firm had revenue of $496.40 million during the quarter, compared to analyst estimates of $496.61 million. During the same period last year, the company earned $0.23 earnings per share. The business’s revenue for the quarter was up 10.7% on a year-over-year basis. Analysts anticipate that The Ensign Group, Inc. will post 1.71 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 31st. Stockholders of record on Sunday, September 30th will be issued a $0.045 dividend. This represents a $0.18 dividend on an annualized basis and a dividend yield of 0.47%. The ex-dividend date is Thursday, September 27th. The Ensign Group’s payout ratio is currently 15.00%.

Several brokerages have weighed in on ENSG. BidaskClub raised The Ensign Group from a “buy” rating to a “strong-buy” rating in a report on Tuesday, July 24th. Zacks Investment Research lowered The Ensign Group from a “buy” rating to a “hold” rating in a report on Wednesday, August 22nd. Cantor Fitzgerald raised their price target on The Ensign Group to $42.00 and gave the stock an “overweight” rating in a report on Tuesday, July 10th. Finally, Stifel Nicolaus set a $34.00 price target on The Ensign Group and gave the stock a “hold” rating in a report on Thursday, August 16th. One analyst has rated the stock with a hold rating and nine have issued a buy rating to the company. The company presently has a consensus rating of “Buy” and an average target price of $38.00.

Several institutional investors have recently bought and sold shares of the company. BlackRock Inc. boosted its holdings in shares of The Ensign Group by 14.1% in the second quarter. BlackRock Inc. now owns 7,187,953 shares of the company’s stock worth $257,471,000 after acquiring an additional 890,137 shares during the period. Dimensional Fund Advisors LP boosted its stake in The Ensign Group by 1.1% during the first quarter. Dimensional Fund Advisors LP now owns 2,286,451 shares of the company’s stock valued at $60,134,000 after buying an additional 23,814 shares during the period. Segall Bryant & Hamill LLC bought a new stake in The Ensign Group during the second quarter valued at $30,968,000. Northern Trust Corp boosted its stake in The Ensign Group by 3.2% during the second quarter. Northern Trust Corp now owns 803,542 shares of the company’s stock valued at $28,782,000 after buying an additional 24,572 shares during the period. Finally, Bank of New York Mellon Corp boosted its stake in The Ensign Group by 4.8% during the second quarter. Bank of New York Mellon Corp now owns 691,990 shares of the company’s stock valued at $24,788,000 after buying an additional 31,850 shares during the period. 84.59% of the stock is owned by hedge funds and other institutional investors.

About The Ensign Group

The Ensign Group, Inc provides health care services in the post-acute care continuum and other ancillary businesses in the United States. It operates through three segments: Transitional and Skilled Services; Assisted and Independent Living Services; and Home Health and Hospice Services. The Transitional and Skilled Services segment offers a range of medical, nursing, rehabilitative, and pharmacy services, as well as routine services, including daily dietary, social, and recreational services to Medicaid, private pay, managed care, and Medicare payors.

Read More: Call Option

Insider Buying and Selling by Quarter for The Ensign Group (NASDAQ:ENSG)

Receive News & Ratings for The Ensign Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Ensign Group and related companies with MarketBeat.com's FREE daily email newsletter.